カテゴリ： 世界, 医療/バイオ, QYResearch

S1P受容体調節薬の世界市場2023年：フィンゴリモド、オザニモド、シポニモド、その他

■ 英語タイトル：Global S1P Receptor Modulator Drugs Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8890）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8890
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：86
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[S1P受容体調節薬の世界市場2023年：フィンゴリモド、オザニモド、シポニモド、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はS1P受容体調節薬のグローバル市場について調査・分析し、世界のS1P受容体調節薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（フィンゴリモド、オザニモド、シポニモド、その他）、用途別セグメント分析（病院薬局、小売店、オンライン薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Novartis International AG、Bristol Myers Squibb、Pfizer Inc.、Sanofi SA、Merck & Co., Inc.、Biogen Inc.、Roche Holding AGなどが含まれています。S1P受容体調節薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、S1P受容体調節薬市場規模を算出する際に考慮しました。

・S1P受容体調節薬市場の概要
- S1P受容体調節薬の種類別セグメント
- 世界のS1P受容体調節薬市場規模：タイプ別分析（フィンゴリモド、オザニモド、シポニモド、その他）
- S1P受容体調節薬の用途別セグメント
- 世界のS1P受容体調節薬市場規模：用途別分析（病院薬局、小売店、オンライン薬局、その他）
- 世界のS1P受容体調節薬市場規模予測（2018年-2029年）

・S1P受容体調節薬市場の成長トレンド
- S1P受容体調節薬の地域別市場規模（2018年-2029年）
- S1P受容体調節薬市場ダイナミクス
- S1P受容体調節薬の業界動向
- S1P受容体調節薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：フィンゴリモド、オザニモド、シポニモド、その他
- 世界のS1P受容体調節薬のタイプ別市場規模（2018年-2023年）
- 世界のS1P受容体調節薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院薬局、小売店、オンライン薬局、その他
- 世界のS1P受容体調節薬の用途別市場規模（2018年-2023年）
- 世界のS1P受容体調節薬の用途別市場規模（2024年-2029年）

・S1P受容体調節薬の地域別市場規模
- 北米のS1P受容体調節薬市場規模（2018年-2029年）
- 米国のS1P受容体調節薬市場規模（2018年-2029年）
- ヨーロッパのS1P受容体調節薬市場規模（2018年-2029年）
- アジア太平洋のS1P受容体調節薬市場規模（2018年-2029年）
- 中国のS1P受容体調節薬市場規模（2018年-2029年）
- 日本のS1P受容体調節薬市場規模（2018年-2029年）
- 韓国のS1P受容体調節薬市場規模（2018年-2029年）
- インドのS1P受容体調節薬市場規模（2018年-2029年）
- オーストラリアのS1P受容体調節薬市場規模（2018年-2029年）
- 中南米のS1P受容体調節薬市場規模（2018年-2029年）
- 中東・アフリカのS1P受容体調節薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Novartis International AG、Bristol Myers Squibb、Pfizer Inc.、Sanofi SA、Merck & Co., Inc.、Biogen Inc.、Roche Holding AG

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global S1P Receptor Modulator Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for S1P Receptor Modulator Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for S1P Receptor Modulator Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for S1P Receptor Modulator Drugs in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of S1P Receptor Modulator Drugs include Novartis International AG, Bristol Myers Squibb, Pfizer Inc., Sanofi SA, Merck & Co., Inc., Biogen Inc. and Roche Holding AG, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for S1P Receptor Modulator Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding S1P Receptor Modulator Drugs.
The S1P Receptor Modulator Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global S1P Receptor Modulator Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the S1P Receptor Modulator Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Novartis International AG
Bristol Myers Squibb
Pfizer Inc.
Sanofi SA
Merck & Co., Inc.
Biogen Inc.
Roche Holding AG
Segment by Type
Fingolimod
Ozanimod
Siponimod
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of S1P Receptor Modulator Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global S1P Receptor Modulator Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Fingolimod
1.2.3 Ozanimod
1.2.4 Siponimod
1.2.5 Others
1.3 Market by Application
1.3.1 Global S1P Receptor Modulator Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global S1P Receptor Modulator Drugs Market Perspective (2018-2029)
2.2 S1P Receptor Modulator Drugs Growth Trends by Region
2.2.1 Global S1P Receptor Modulator Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 S1P Receptor Modulator Drugs Historic Market Size by Region (2018-2023)
2.2.3 S1P Receptor Modulator Drugs Forecasted Market Size by Region (2024-2029)
2.3 S1P Receptor Modulator Drugs Market Dynamics
2.3.1 S1P Receptor Modulator Drugs Industry Trends
2.3.2 S1P Receptor Modulator Drugs Market Drivers
2.3.3 S1P Receptor Modulator Drugs Market Challenges
2.3.4 S1P Receptor Modulator Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top S1P Receptor Modulator Drugs Players by Revenue
3.1.1 Global Top S1P Receptor Modulator Drugs Players by Revenue (2018-2023)
3.1.2 Global S1P Receptor Modulator Drugs Revenue Market Share by Players (2018-2023)
3.2 Global S1P Receptor Modulator Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by S1P Receptor Modulator Drugs Revenue
3.4 Global S1P Receptor Modulator Drugs Market Concentration Ratio
3.4.1 Global S1P Receptor Modulator Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by S1P Receptor Modulator Drugs Revenue in 2022
3.5 S1P Receptor Modulator Drugs Key Players Head office and Area Served
3.6 Key Players S1P Receptor Modulator Drugs Product Solution and Service
3.7 Date of Enter into S1P Receptor Modulator Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 S1P Receptor Modulator Drugs Breakdown Data by Type
4.1 Global S1P Receptor Modulator Drugs Historic Market Size by Type (2018-2023)
4.2 Global S1P Receptor Modulator Drugs Forecasted Market Size by Type (2024-2029)
5 S1P Receptor Modulator Drugs Breakdown Data by Application
5.1 Global S1P Receptor Modulator Drugs Historic Market Size by Application (2018-2023)
5.2 Global S1P Receptor Modulator Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America S1P Receptor Modulator Drugs Market Size (2018-2029)
6.2 North America S1P Receptor Modulator Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America S1P Receptor Modulator Drugs Market Size by Country (2018-2023)
6.4 North America S1P Receptor Modulator Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe S1P Receptor Modulator Drugs Market Size (2018-2029)
7.2 Europe S1P Receptor Modulator Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe S1P Receptor Modulator Drugs Market Size by Country (2018-2023)
7.4 Europe S1P Receptor Modulator Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific S1P Receptor Modulator Drugs Market Size (2018-2029)
8.2 Asia-Pacific S1P Receptor Modulator Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific S1P Receptor Modulator Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific S1P Receptor Modulator Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America S1P Receptor Modulator Drugs Market Size (2018-2029)
9.2 Latin America S1P Receptor Modulator Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America S1P Receptor Modulator Drugs Market Size by Country (2018-2023)
9.4 Latin America S1P Receptor Modulator Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa S1P Receptor Modulator Drugs Market Size (2018-2029)
10.2 Middle East & Africa S1P Receptor Modulator Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis International AG
11.1.1 Novartis International AG Company Detail
11.1.2 Novartis International AG Business Overview
11.1.3 Novartis International AG S1P Receptor Modulator Drugs Introduction
11.1.4 Novartis International AG Revenue in S1P Receptor Modulator Drugs Business (2018-2023)
11.1.5 Novartis International AG Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Detail
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb S1P Receptor Modulator Drugs Introduction
11.2.4 Bristol Myers Squibb Revenue in S1P Receptor Modulator Drugs Business (2018-2023)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Detail
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. S1P Receptor Modulator Drugs Introduction
11.3.4 Pfizer Inc. Revenue in S1P Receptor Modulator Drugs Business (2018-2023)
11.3.5 Pfizer Inc. Recent Development
11.4 Sanofi SA
11.4.1 Sanofi SA Company Detail
11.4.2 Sanofi SA Business Overview
11.4.3 Sanofi SA S1P Receptor Modulator Drugs Introduction
11.4.4 Sanofi SA Revenue in S1P Receptor Modulator Drugs Business (2018-2023)
11.4.5 Sanofi SA Recent Development
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Detail
11.5.2 Merck & Co., Inc. Business Overview
11.5.3 Merck & Co., Inc. S1P Receptor Modulator Drugs Introduction
11.5.4 Merck & Co., Inc. Revenue in S1P Receptor Modulator Drugs Business (2018-2023)
11.5.5 Merck & Co., Inc. Recent Development
11.6 Biogen Inc.
11.6.1 Biogen Inc. Company Detail
11.6.2 Biogen Inc. Business Overview
11.6.3 Biogen Inc. S1P Receptor Modulator Drugs Introduction
11.6.4 Biogen Inc. Revenue in S1P Receptor Modulator Drugs Business (2018-2023)
11.6.5 Biogen Inc. Recent Development
11.7 Roche Holding AG
11.7.1 Roche Holding AG Company Detail
11.7.2 Roche Holding AG Business Overview
11.7.3 Roche Holding AG S1P Receptor Modulator Drugs Introduction
11.7.4 Roche Holding AG Revenue in S1P Receptor Modulator Drugs Business (2018-2023)
11.7.5 Roche Holding AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global S1P Receptor Modulator Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Fingolimod
Table 3. Key Players of Ozanimod
Table 4. Key Players of Siponimod
Table 5. Key Players of Others
Table 6. Global S1P Receptor Modulator Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global S1P Receptor Modulator Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global S1P Receptor Modulator Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global S1P Receptor Modulator Drugs Market Share by Region (2018-2023)
Table 10. Global S1P Receptor Modulator Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global S1P Receptor Modulator Drugs Market Share by Region (2024-2029)
Table 12. S1P Receptor Modulator Drugs Market Trends
Table 13. S1P Receptor Modulator Drugs Market Drivers
Table 14. S1P Receptor Modulator Drugs Market Challenges
Table 15. S1P Receptor Modulator Drugs Market Restraints
Table 16. Global S1P Receptor Modulator Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global S1P Receptor Modulator Drugs Market Share by Players (2018-2023)
Table 18. Global Top S1P Receptor Modulator Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in S1P Receptor Modulator Drugs as of 2022)
Table 19. Ranking of Global Top S1P Receptor Modulator Drugs Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by S1P Receptor Modulator Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players S1P Receptor Modulator Drugs Product Solution and Service
Table 23. Date of Enter into S1P Receptor Modulator Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global S1P Receptor Modulator Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global S1P Receptor Modulator Drugs Revenue Market Share by Type (2018-2023)
Table 27. Global S1P Receptor Modulator Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global S1P Receptor Modulator Drugs Revenue Market Share by Type (2024-2029)
Table 29. Global S1P Receptor Modulator Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global S1P Receptor Modulator Drugs Revenue Market Share by Application (2018-2023)
Table 31. Global S1P Receptor Modulator Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global S1P Receptor Modulator Drugs Revenue Market Share by Application (2024-2029)
Table 33. North America S1P Receptor Modulator Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America S1P Receptor Modulator Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America S1P Receptor Modulator Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe S1P Receptor Modulator Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe S1P Receptor Modulator Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe S1P Receptor Modulator Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific S1P Receptor Modulator Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific S1P Receptor Modulator Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific S1P Receptor Modulator Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America S1P Receptor Modulator Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America S1P Receptor Modulator Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America S1P Receptor Modulator Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa S1P Receptor Modulator Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 48. Novartis International AG Company Detail
Table 49. Novartis International AG Business Overview
Table 50. Novartis International AG S1P Receptor Modulator Drugs Product
Table 51. Novartis International AG Revenue in S1P Receptor Modulator Drugs Business (2018-2023) & (US$ Million)
Table 52. Novartis International AG Recent Development
Table 53. Bristol Myers Squibb Company Detail
Table 54. Bristol Myers Squibb Business Overview
Table 55. Bristol Myers Squibb S1P Receptor Modulator Drugs Product
Table 56. Bristol Myers Squibb Revenue in S1P Receptor Modulator Drugs Business (2018-2023) & (US$ Million)
Table 57. Bristol Myers Squibb Recent Development
Table 58. Pfizer Inc. Company Detail
Table 59. Pfizer Inc. Business Overview
Table 60. Pfizer Inc. S1P Receptor Modulator Drugs Product
Table 61. Pfizer Inc. Revenue in S1P Receptor Modulator Drugs Business (2018-2023) & (US$ Million)
Table 62. Pfizer Inc. Recent Development
Table 63. Sanofi SA Company Detail
Table 64. Sanofi SA Business Overview
Table 65. Sanofi SA S1P Receptor Modulator Drugs Product
Table 66. Sanofi SA Revenue in S1P Receptor Modulator Drugs Business (2018-2023) & (US$ Million)
Table 67. Sanofi SA Recent Development
Table 68. Merck & Co., Inc. Company Detail
Table 69. Merck & Co., Inc. Business Overview
Table 70. Merck & Co., Inc. S1P Receptor Modulator Drugs Product
Table 71. Merck & Co., Inc. Revenue in S1P Receptor Modulator Drugs Business (2018-2023) & (US$ Million)
Table 72. Merck & Co., Inc. Recent Development
Table 73. Biogen Inc. Company Detail
Table 74. Biogen Inc. Business Overview
Table 75. Biogen Inc. S1P Receptor Modulator Drugs Product
Table 76. Biogen Inc. Revenue in S1P Receptor Modulator Drugs Business (2018-2023) & (US$ Million)
Table 77. Biogen Inc. Recent Development
Table 78. Roche Holding AG Company Detail
Table 79. Roche Holding AG Business Overview
Table 80. Roche Holding AG S1P Receptor Modulator Drugs Product
Table 81. Roche Holding AG Revenue in S1P Receptor Modulator Drugs Business (2018-2023) & (US$ Million)
Table 82. Roche Holding AG Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global S1P Receptor Modulator Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global S1P Receptor Modulator Drugs Market Share by Type: 2022 VS 2029
Figure 3. Fingolimod Features
Figure 4. Ozanimod Features
Figure 5. Siponimod Features
Figure 6. Others Features
Figure 7. Global S1P Receptor Modulator Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global S1P Receptor Modulator Drugs Market Share by Application: 2022 VS 2029
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. S1P Receptor Modulator Drugs Report Years Considered
Figure 14. Global S1P Receptor Modulator Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global S1P Receptor Modulator Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global S1P Receptor Modulator Drugs Market Share by Region: 2022 VS 2029
Figure 17. Global S1P Receptor Modulator Drugs Market Share by Players in 2022
Figure 18. Global Top S1P Receptor Modulator Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in S1P Receptor Modulator Drugs as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by S1P Receptor Modulator Drugs Revenue in 2022
Figure 20. North America S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America S1P Receptor Modulator Drugs Market Share by Country (2018-2029)
Figure 22. United States S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe S1P Receptor Modulator Drugs Market Share by Country (2018-2029)
Figure 26. Germany S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific S1P Receptor Modulator Drugs Market Share by Region (2018-2029)
Figure 34. China S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America S1P Receptor Modulator Drugs Market Share by Country (2018-2029)
Figure 42. Mexico S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa S1P Receptor Modulator Drugs Market Share by Country (2018-2029)
Figure 46. Turkey S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia S1P Receptor Modulator Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Novartis International AG Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2018-2023)
Figure 49. Bristol Myers Squibb Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2018-2023)
Figure 50. Pfizer Inc. Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2018-2023)
Figure 51. Sanofi SA Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2018-2023)
Figure 52. Merck & Co., Inc. Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2018-2023)
Figure 53. Biogen Inc. Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2018-2023)
Figure 54. Roche Holding AG Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • エンドセリン受容体拮抗薬の世界市場2023年：アンブリセンタン、ボセンタン、マシテンタン
  • バソプレシンV1b受容体のグローバル市場展望 2023年-2029年：PHT-103、ABT-436、AVN-628、その他
  • C5aアナフィラトキシン走化性受容体1のグローバル市場展望 2023年-2029年：EP-67、NOXD-19、NOXD-20、DF-2593A、その他
  • 液晶変調器のグローバル市場展望 2023年-2029年：偏波変調器、振幅変調器、位相変調器、その他
  • 高カリウム血症治療薬の世界市場2023年：パティロマー、シクロケイ酸ジルコニウムナトリウム
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8890 )"S1P受容体調節薬の世界市場2023年：フィンゴリモド、オザニモド、シポニモド、その他" (英文：Global S1P Receptor Modulator Drugs Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。